World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03019458
Date of registration: 09/01/2017
Prospective Registration: Yes
Primary sponsor: Sunshine Care Foundation
Public title: MINGO Supplemental Trial in X-linked Dystonia-Parkinsonism Patients MINGO
Scientific title: MINGO Supplemental Trial in X-linked Dystonia Parkinsonism Patients: A Prospective Randomized, Open-labeled, Parallel Group Trial
Date of first enrolment: February 10, 2017
Target sample size: 50
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03019458
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Philippines
Contacts
Name:     Criscely L Go, MD,FPNA,DPBP
Address: 
Telephone:
Email:
Affiliation:  Jose R. Reyes Memorial Medical Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- Subject is above the age of 18

- Positive Diagnosis of XDP by movement disorder specialist/fellow

- Subject with a yes response to a "supportive home environment" in the patient's most
recent "doctors monthly report"

- Subject are easily accessible to passable roads and pubic transportation

Exclusion Criteria:

- Subjects who have extreme movements that prevent staff from performing BMI or MUAC
measurements

- Subjects who have abnormal metabolic labs prior to the start of the study

- Subjects who are taking pharmacological or medicinal supplements that may effect
weight

- Subjects who have been hospitalized within the last 2 weeks from the start of the
trial

- Subjects who have a Nasogastric tube or G-tube

- Subjects with a history of other diseases that my effect weight (eg:
hypo/hyperthyroidism)



Age minimum: 18 Years
Age maximum: 90 Years
Gender: All
Health Condition(s) or Problem(s) studied
X-Linked Dystonia Parkinsonism
Intervention(s)
Dietary Supplement: MINGO
Primary Outcome(s)
The Body Mass Index (BMI in kg/m^2) Using a Bathroom Weighing Scale. [Time Frame: after baseline Body Mass Index, we will measure Body Mass Index every 2 weeks for 3 months]
Secondary Outcome(s)
Number of Hospitalizations Secondary to Infectious Causes [Time Frame: 3 months (study close out)]
Mid Upper Arm Circumference (MUAC) in cm Using a Tailor's Tape Measure [Time Frame: After baseline measurements, the investigators will measure the MUAC evey month for 3 months]
All Cause Mortality [Time Frame: 3 months (study close out)]
Secondary ID(s)
MINGO-001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Jose R. Reyes Memorial Medical Center
Massachusetts General Hospital
Ethics review
Results
Results available: Yes
Date Posted: 06/04/2020
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT03019458
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history